☆ 4.5 Editorial Material

Invited Commentary Anti-Inflammatory Effects of Metabolic Surgery

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2023)

Related references

Note: Only part of the references are listed.
Article Surgery

Impact of Rapid Weight Loss after Bariatric Surgery in Systemic Inflammatory Response and Pulmonary Hemodynamics in Severely Obese Subjects with Pulmonary Hypertension

Roberto J. Valera et al.

Summary: This study aimed to describe the changes in pulmonary arterial pressures and systemic inflammation in patients with obesity with PH after bariatric surgery. The results showed that bariatric surgery could decrease pulmonary arterial pressures and systemic inflammation in obese patients with PH, although the correlation was not statistically significant.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2023)

Add to Collection
Article Surgery

2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery

Dan Eisenberg et al.

Summary: Major updates to the 1991 National Institutes of Health guidelines for bariatric surgery recommend metabolic and bariatric surgery (MBS) for individuals with a body mass index (BMI) >35 kg/m2 regardless of co-morbidities. It is also suggested that individuals with metabolic disease and a BMI of 30-34.9 kg/m2 should consider MBS. Furthermore, BMI thresholds should be adjusted for the Asian population, with a BMI >25 kg/m2 indicating clinical obesity, and MBS offered to individuals with a BMI >27.5 kg/m2. The long-term safety and efficacy of MBS have been consistently demonstrated, and selected children and adolescents may also be considered for MBS.

SURGERY FOR OBESITY AND RELATED DISEASES (2022)

Add to Collection
Review Surgery

Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies

Benjamin Clapp et al.

Summary: Bariatric surgery is associated with a reduced risk of non-hormonal cancers. This systematic review evaluated 15 studies with a total of 18,583,477 patients and found a lower incidence of non-hormonal cancer in patients after bariatric surgery compared to a non-surgical control.

BRITISH JOURNAL OF SURGERY (2022)

Add to Collection
Article Surgery

Long-Term Improvement of Chronic Low-Grade Inflammation After Bariatric Surgery

Anne Lautenbach et al.

Summary: Bariatric surgery can reduce obesity-related chronic low-grade inflammation for up to 4 years after the surgery, with improvement related to changes in BMI and remission of T2D in the long-term.

OBESITY SURGERY (2021)

Add to Collection
Article Surgery

Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics

Isolina Rossi et al.

Summary: Laparoscopic Roux-en-Y gastric bypass surgery may reduce inflammatory markers and cardiovascular disease risk factors in obese patients with diabetes, with a significant correlation between decreased interleukin-6 levels and weight loss as well as lowered blood pressure.

SURGERY (2021)

Add to Collection
Review Endocrinology & Metabolism

Impact of Bariatric Surgery on White Adipose Tissue Inflammation

Jennifer Labrecque et al.

CANADIAN JOURNAL OF DIABETES (2017)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.